Skip to main content
Equibles

STATE STREET CORP

Position in SPRO — Spero Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to SPRO Full portfolio

Position in SPRO

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$474,599
-$27,918 QoQ
Shares Held
214,751
0.0% QoQ
Ownership
0.369%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 59 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 72% Shared 0% None 28%

Common Shares in SPRO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. SPRO ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SPRO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $474,599 214,751
2026-03-31 $502,517 214,751
2025-12-31 $489,651 210,151
2025-09-30 $358,987 190,951
2025-06-30 $445,007 153,451
2025-03-31 $107,215 148,911
2024-12-31 $153,378 148,911
2024-09-30 $174,884 130,511
2024-06-30 $169,664 130,511
2024-03-31 $224,478 130,511
2023-12-31 $191,851 130,511
2023-09-30 $157,918 130,511
2023-06-30 $160,530 110,711
2023-03-31 $160,530 110,711
2022-12-31 $191,530 110,711
2022-09-30 $182,622 91,311
2022-06-30 $74,384 100,384
2022-03-31 $4,325,509 497,185
2021-12-31 $13,511,719 843,955
2021-09-30 $14,777,541 802,691
2021-06-30 $11,317,902 810,738
2021-03-31 $19,968,312 1,356,543
2020-12-31 $6,569,933 338,831
2020-09-30 $3,187,206 285,592
2020-06-30 $3,904,406 288,574
2020-03-31 $2,249,819 278,443